Aslı Kavaz
Ankara University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Aslı Kavaz.
American Journal of Human Genetics | 2011
Asli Sirmaci; Michail Spiliopoulos; Francesco Brancati; Eric Powell; Duygu Duman; Alex Abrams; Guney Bademci; Emanuele Agolini; Shengru Guo; Berrin Konuk; Aslı Kavaz; Susan H. Blanton; Maria Christina Digilio; Bruno Dallapiccola; Juan Young; Stephan Züchner; Mustafa Tekin
KBG syndrome is characterized by intellectual disability associated with macrodontia of the upper central incisors as well as distinct craniofacial findings, short stature, and skeletal anomalies. Although believed to be genetic in origin, the specific underlying defect is unknown. Through whole-exome sequencing, we identified deleterious heterozygous mutations in ANKRD11 encoding ankyrin repeat domain 11, also known as ankyrin repeat-containing cofactor 1. A splice-site mutation, c.7570-1G>C (p.Glu2524_Lys2525del), cosegregated with the disease in a family with three affected members, whereas in a simplex case a de novo truncating mutation, c.2305delT (p.Ser769GlnfsX8), was detected. Sanger sequencing revealed additional de novo truncating ANKRD11 mutations in three other simplex cases. ANKRD11 is known to interact with nuclear receptor complexes to modify transcriptional activation. We demonstrated that ANKRD11 localizes mainly to the nuclei of neurons and accumulates in discrete inclusions when neurons are depolarized, suggesting that it plays a role in neural plasticity. Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.
American Journal of Human Genetics | 2013
Helen M. Stuart; Neil A. Roberts; Berk Burgu; Sarah B. Daly; Jill Urquhart; Sanjeev Bhaskar; Jonathan E. Dickerson; Murat Mermerkaya; Mesrur Selcuk Silay; Malcolm Lewis; M. Beatriz Orive Olondriz; Blanca Gener; Christian Beetz; Rita Eva Varga; Ömer Gülpınar; Evren Süer; Tarkan Soygür; Zeynep Birsin Özçakar; Fatoş Yalçınkaya; Aslı Kavaz; Burcu Bulum; Adnan Gucuk; W.W. Yue; Firat Erdogan; Andrew Berry; Neil A. Hanley; Edward A. McKenzie; Emma Hilton; Adrian S. Woolf; William G. Newman
Urofacial syndrome (UFS) (or Ochoa syndrome) is an autosomal-recessive disease characterized by congenital urinary bladder dysfunction, associated with a significant risk of kidney failure, and an abnormal facial expression upon smiling, laughing, and crying. We report that a subset of UFS-affected individuals have biallelic mutations in LRIG2, encoding leucine-rich repeats and immunoglobulin-like domains 2, a protein implicated in neural cell signaling and tumorigenesis. Importantly, we have demonstrated that rare variants in LRIG2 might be relevant to nonsyndromic bladder disease. We have previously shown that UFS is also caused by mutations in HPSE2, encoding heparanase-2. LRIG2 and heparanase-2 were immunodetected in nerve fascicles growing between muscle bundles within the human fetal bladder, directly implicating both molecules in neural development in the lower urinary tract.
Acta Paediatrica | 2012
Aslı Kavaz; Z. Birsin Özçakar; Tanıl Kendirli; Burcu Öztürk; Mesiha Ekim; Fatoş Yalçınkaya
Aim: The purpose of our study was to evaluate and analyse the prevalence and association of acute kidney injury (AKI) as defined by paediatric Risk, Injury, Failure, Loss of kidney function and End‐stage kidney disease (pRIFLE) and Acute Kidney Injury Network (AKIN) classifications in a paediatric intensive care unit (PICU).
Acta Paediatrica | 2011
Zeynep Birsin Özçakar; Fatoş Yalçınkaya; Aslı Kavaz; Gülsüm Kadıoğlu; Atilla Halil Elhan; Derya Aysev; Haluk Güriz; Mesiha Ekim
Aim: Urinary tract infections (UTIs) caused by extended‐spectrum beta lactamase (ESBL)‐producing bacteria have become a growing problem worldwide. The aim of this study was to investigate the clinical and radiological findings in patients with community‐acquired UTIs owing to ESBL‐producing bacteria.
Pediatrics International | 2007
Tanıl Kendirli; Mesiha Ekim; Zeynep Birsin Özçakar; Selçuk Yüksel; Banu Acar; Burcu Öztürk‐Hiişmi; Emel Derelli; Aslı Kavaz; Zahide Yalaki; F. Yalçinkaya
Background: Despite constant improvements in caring for critically ill neonates and infants with congenital cardiac disease, sepsis, bone marrow and solid organ transplantation, acute renal failure (ARF) is an important problem in these children. ARF, severe fluid overload and inborn errors of metabolism are some of the indications for acute dialysis in infants and children.
American Journal of Medical Genetics Part A | 2004
Mustafa Tekin; Aslı Kavaz; Merih Berberoglu; Suat Fitoz; Mesiha Ekim; Gönül Öcal; Nejat Akar
We report on a Turkish family in which the father and his two sons were diagnosed as having the KBG syndrome. Large upper central incisors were the diagnostic finding in all three patients along with mental retardation, cryptorchidism, skeletal abnormalities, and short stature. Our report clearly confirms that the inheritance is autosomal dominant in KBG syndrome, although a high male to female ratio has been observed in published cases.
Nephrology Dialysis Transplantation | 2013
Rukshana Shroff; Constantinos J. Stefanidis; Varvara Askiti; Alberto Edefonti; Sara Testa; Mesiha Ekim; Aslı Kavaz; Gema Ariceta; Sevcan A. Bakkaloglu; Michel Fischbach; Günter Klaus; Aleksandra Zurowska; Tuula Hölttä; Augustina Jankauskiene; Karel Vondrak; Johan Vande Walle; Claus Peter Schmitt; Alan R. Watson
BACKGROUND Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis (PD) that is associated with significant morbidity and mortality in adults. There are scarce data for children. We performed a 10-year survey to determine the prevalence, risk factors and outcome for EPS in children. METHODS Chronic PD patients in 14 dialysis units participating in the European Paediatric Dialysis Working Group between January 2001 and December 2010 were included in this study. RESULTS Twenty-two cases of EPS were reported (prevalence 1.5%; 8.7 per 1000 patient-years on PD). Median PD vintage was 5.9 (1.6-10.2) in EPS and 1.7 (0.7-7.7) years in the remainder of the PD population (P<0.0001). EPS patients had a significantly higher peritonitis rate than non-EPS patients (P=0.2). EPS was diagnosed while the child was on PD in 17 (77%), after conversion to haemodialysis (HD) in 3 and after transplantation in 2. Fifteen of 17 (88%) developed ultrafiltration (UF) failure. The median interval between UF failure and presentation with bowel obstruction was 2.8 (0.02-5.8) months. Twenty (91%) had clinical and radiological signs of bowel obstruction. Enterolysis was performed in 14 and 19 received immunosuppression or tamoxifen. Nine required parenteral nutrition. At final follow-up 4.8 (1.3-8.7) years after EPS diagnosis, 3 patients died, 11 had a functioning transplant and 8 were on HD. CONCLUSIONS The prevalence of EPS in European children on PD is comparable with that of adult PD patients, but mortality from paediatric EPS is significantly lower. A high index of suspicion is required for the diagnosis of EPS in children with longer dialysis duration, a high peritonitis rate and UF failure.
Rheumatology International | 2013
Z. Birsin Özçakar; Fatoş Yalçınkaya; F. Şemsa Altugan; Aslı Kavaz; Arzu Ensari; Mesiha Ekim
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is relatively uncommon and generally seen in the fourth decade of life. There are very few pediatric cases with the diagnosis of HUVS in the literature. In this report, we describe the first familial cases of HUVS in three siblings. The disease onset was during childhood period in all patients. One of them developed severe renal involvement and died. The other two had ongoing skin and eye manifestations and the elder one developed lupus. Presence of these three patients is a strong evidence for the role of genetic factors in the pathogenesis of this rare vasculitis.
Acta Paediatrica | 2014
Burcu Bulum; Zeynep Birsin Özçakar; Aslı Kavaz; Mehriban Hüseynova; Mesiha Ekim; Fatoş Yalçınkaya
Previous studies suggest that 6–46% of children suffer from lower urinary tract dysfunction (LUTD). This study evaluated the prevalence of LUTD in children with a urinary tract infection (UTI) and assessed the impact of standard urotherapy on patients with LUTD.
Nephron | 2016
Songül Yılmaz; Z. Birsin Özçakar; Eda Didem Kurt Şükür; Burcu Bulum; Aslı Kavaz; Atilla Halil Elhan; Fatoş Yalçınkaya
Background/Aims: There are many controversies regarding the best approach for evaluating children after their first febrile urinary tract infection (UTI). The aim of this study was to define the clinical, laboratory, and radiological features of patients with their first febrile UTI and to investigate the factors that might predict the presence of vesicoureteral reflux (VUR) and renal scarring. Methods: The files of patients who were followed due to their first febrile UTI between 2008 and 2013 were retrospectively reviewed (n = 300). Patients were divided into groups based on their age, the resistance state of microorganisms, the presence of VUR, and scarring on Tc99m dimercaptosuccinic acid scintigraphy. The chi-square test and Mann-Whitney U test were used for analysis. Results: The median age at the first febrile UTI was 11 months and girls constituted 77% of the patient population. VUR and renal scarring were detected in 30.9 and 19.4% of the patients, respectively. C-reactive protein levels and the presence of renal scarring were significantly higher in patients with VUR (p < 0.05). Abnormal ultrasonography findings, VUR and recurrent UTIs were significantly higher in patients with renal scars (p < 0.001). In multivariate analysis, we did not detect any factor that might predict the presence of VUR and renal scarring. Conclusion: A majority of children had their first febrile UTI at a young age. Although we could not find any factor that might predict the VUR and scar risk in patients with their first febrile UTI, an abnormal renal scan at 6 months after infection was closely related with the presence of VUR and recurrent UTIs.